141 related articles for article (PubMed ID: 38612616)
1. Pre-mRNA splicing defects and RNA binding protein involvement in Niemann Pick type C disease.
Paron F; Dardis A; Buratti E
J Biotechnol; 2020 Jul; 318():20-30. PubMed ID: 32387451
[TBL] [Abstract][Full Text] [Related]
2. Alterations in Proteostasis Mechanisms in Niemann-Pick Type C Disease.
Servín Muñoz IV; Ortuño-Sahagún D; Griñán-Ferré C; Pallàs M; González-Castillo C
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612616
[TBL] [Abstract][Full Text] [Related]
3. Correction of Niemann-Pick type C1 trafficking and activity with the histone deacetylase inhibitor valproic acid.
Subramanian K; Hutt DM; Scott SM; Gupta V; Mao S; Balch WE
J Biol Chem; 2020 Jun; 295(23):8017-8035. PubMed ID: 32354745
[TBL] [Abstract][Full Text] [Related]
4. The potential of histone deacetylase inhibitors in Niemann - Pick type C disease.
Maceyka M; Milstien S; Spiegel S
FEBS J; 2013 Dec; 280(24):6367-72. PubMed ID: 23992240
[TBL] [Abstract][Full Text] [Related]
5. Quantitative Analysis of the Proteome Response to the Histone Deacetylase Inhibitor (HDACi) Vorinostat in Niemann-Pick Type C1 disease.
Subramanian K; Rauniyar N; Lavalleé-Adam M; Yates JR; Balch WE
Mol Cell Proteomics; 2017 Nov; 16(11):1938-1957. PubMed ID: 28860124
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitors correct the cholesterol storage defect in most Niemann-Pick C1 mutant cells.
Pipalia NH; Subramanian K; Mao S; Ralph H; Hutt DM; Scott SM; Balch WE; Maxfield FR
J Lipid Res; 2017 Apr; 58(4):695-708. PubMed ID: 28193631
[TBL] [Abstract][Full Text] [Related]
7. Ryanodine receptor antagonists adapt NPC1 proteostasis to ameliorate lipid storage in Niemann-Pick type C disease fibroblasts.
Yu T; Chung C; Shen D; Xu H; Lieberman AP
Hum Mol Genet; 2012 Jul; 21(14):3205-14. PubMed ID: 22505584
[TBL] [Abstract][Full Text] [Related]
8. Intracellular Ca
Moccia F; Fiorio Pla A; Lim D; Lodola F; Gerbino A
Front Physiol; 2023; 14():1210085. PubMed ID: 37576340
[TBL] [Abstract][Full Text] [Related]
9. Elevated cerebrospinal fluid ubiquitin C-terminal hydrolase-L1 levels correlate with phenotypic severity and therapeutic response in Niemann-Pick disease, type C1.
Cawley NX; Giddens S; Farhat NM; Luke RA; Scott KEJ; Mohamed HO; Dang Do A; Berry-Kravis E; Cologna SM; Liu F; Porter FD
Mol Genet Metab; 2023 Nov; 140(3):107656. PubMed ID: 37517328
[TBL] [Abstract][Full Text] [Related]
10. ER-phagy in neurodegeneration.
Hill MA; Sykes AM; Mellick GD
J Neurosci Res; 2023 Oct; 101(10):1611-1623. PubMed ID: 37334842
[TBL] [Abstract][Full Text] [Related]
11. Investigation of 2-Hydroxypropyl-β-Cyclodextrin Treatment in a Neuronal-Like Cell Model of Niemann-Pick Type C Using Quantitative Proteomics.
Cougnoux A; Pergande MR; Serna-Perez F; Cologna SM
J Am Soc Mass Spectrom; 2023 Apr; 34(4):668-675. PubMed ID: 36920149
[TBL] [Abstract][Full Text] [Related]
12. Role of UCHL1 in the pathogenesis of neurodegenerative diseases and brain injury.
Mi Z; Graham SH
Ageing Res Rev; 2023 Apr; 86():101856. PubMed ID: 36681249
[TBL] [Abstract][Full Text] [Related]
13. Heat shock protein amplification improves cerebellar myelination in the Npc1
Gray J; Fernández-Suárez ME; Falah M; Smith D; Smith C; Kaya E; Palmer AM; Fog CK; Kirkegaard T; Platt FM
EBioMedicine; 2022 Dec; 86():104374. PubMed ID: 36455410
[TBL] [Abstract][Full Text] [Related]
14. Species-specific differences in NPC1 protein trafficking govern therapeutic response in Niemann-Pick type C disease.
Schultz ML; Schache KJ; Azaria RD; Kuiper EQ; Erwood S; Ivakine EA; Farhat NY; Porter FD; Pathmasiri KC; Cologna SM; Uhler MD; Lieberman AP
JCI Insight; 2022 Dec; 7(23):. PubMed ID: 36301667
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]